Neuroflow acquired Intermountain Health’s behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on…
This interactive map shows the increase in states with laws restricting abortion coverage in Medicaid and private insurance since 2010.
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagos’s headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B appeared first on MedCity News.
Leader of one of the largest hospital-at-home programs calls it ‘one of the most disruptive elements of care delivery that we’ve had in a generation’
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO market’s return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on…
Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Don’t Work in Workplace Wellness appeared first on MedCity News.
When it comes to managing inbound phone calls, underperformance has devastating cost implications. The post What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations appeared first on MedCity News.
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health appeared first on MedCity News.
HELENA, Mont. — A last-minute change to a 2019 bill put an end date on Montana’s Medicaid expansion program, setting the stage for what is anticipated to be the most significant health care debate of the 2025 Montana Legislature. In recent interviews, legislative leaders predicted a vigorous debate over keeping the Medicaid expansion program, which…